Valeritas

Biotech & Life Sciences · Bridgewater Township, United States · Founded 2006 · IPO 2017

Valeritas is a pharmaceutical company specializing in the development of innovative peptide-based therapeutics aimed at treating metabolic and rare diseases. The company operates in the biopharmaceutical market, focusing on creating next-generation peptide medicines that address significant unmet medical needs. Valeritas serves patients suffering from conditions such as diabetes, congenital hyperinsulinism, and short bowel syndrome, among others. The business model revolves around research and development, advancing its proprietary peptide platform through various clinical stages, including Phase 3 trials for some of its key programs. Revenue is generated through the commercialization of its developed therapies, partnerships, and licensing agreements. The company is committed to transforming lives by providing advanced therapeutic solutions and has a robust pipeline of products in late-stage development. Keywords: peptide therapeutics, metabolic diseases, rare diseases, diabetes, congenital hyperinsulinism, short bowel syndrome, Phase 3 trials, biopharmaceutical, proprietary platform, clinical development.

Valuation $100–500M

Revenue $10–50M

Headcount <100

Total funding $100–500M

Power Law Colt$25–100M revenue

Investors

12 investors on Valeritas's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 7 investors entered at this stage

U.S. Venture Partners

MPM BioImpact

Pitango Venture Capital

Abingworth

HLM Venture Partners

Onset Ventures

Advanced Technology Ventures

Series B+ 5 investors entered at this stage

Agate Medical Investments

CHL Medical Partners

Welsh, Carson, Anderson & Stowe

Kaiser Permanente Ventures

CRG LP

Global footprint

Where Valeritas has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States92.3%

1 country shown

Web traffic by country

1.2K monthly visits
across markets

🇧🇷 Brazil50%

🇸🇪 Sweden50%

🇮🇹 Italy0%

Top 3 markets shown

Talent graph

The shape of Valeritas's talent

Dealroom maps Valeritas's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

20 team members profilednamed & role-tagged by Dealroom

34 employeestotal headcount

4 executives & foundersidentified by name

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock Valeritas's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Valeritas

An AI-synthesized read of the highest-engagement posts about Valeritas on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Valeritas on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles